BRCA1/2突变携带者卵巢癌后乳腺癌风险
本研究纳入960例BRCA1/2突变且患卵巢癌的女性,比较其与741例年龄匹配无卵巢癌的BRCA携带者的乳腺癌累积风险。
要点
- BRCA携带者卵巢癌后乳腺癌15年累积风险仅11.5%
- 不推荐常规预防性乳房切除,可考虑MRI和/或钼靶监测
核心结论
- BRCA携带者患卵巢癌后乳腺癌风险相对较低,不推荐常规预防性乳房切除,长期生存者可考虑,MRI监测和/或钼靶是现实替代方案。
研究设计与样本
- 纳入960例BRCA1/2致病/可能致病突变、有卵巢癌诊断、无其他癌症史且未行降低风险双侧乳房切除的女性,从卵巢癌诊断或基线问卷较晚日期起随访乳腺癌发生。
- 与741例年龄匹配的无卵巢癌BRCA携带者对照比较5、10、15年乳腺癌累积风险。
主要发现
- 中位随访4.9年,41例(4.3%)发生乳腺癌,平均诊断年龄57.5岁(范围39-74)。
- 卵巢癌后5、10、15年乳腺癌累积风险分别为4.4%、8.9%、11.5%。
- 仅3例发生乳腺癌相关死亡。
- 无卵巢癌BRCA携带者5、10、15年乳腺癌累积风险分别为20.9%、38.6%、47.2%。
临床怎么用
- BRCA携带者卵巢癌后不推荐常规预防性乳房切除。
- 长期生存者可考虑预防性乳房切除。
- MRI监测和/或钼靶是现实替代监测方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: BRCA carriers face high risks of developing both breast and ovarian/fallopian tube cancers (hereafter referred to as ovarian). Among BRCA carriers with ovarian cancer, it is not clear whether the risk of breast cancer is sufficiently high that risk-reducing mastectomy should be offered. This study aimed to assess the risk of breast cancer BRCA carriers after a diagnosis of ovarian cancer. METHODS: We included women with a pathogenic/likely pathogenic variant in BRCA1 or BRCA2, a diagnosis of ovarian cancer, and no other cancer history and no risk-reducing bilateral mastectomy. Women were followed for incident breast cancer from the date of ovarian cancer diagnosis or the date of baseline questionnaire, whichever came last. The 5-, 10-, and 15-year cumulative risks of breast cancer were compared for women with ovarian cancer and an age-matched set of control women without ovarian cancer. RESULTS: A total of 960 participants with ovarian cancer were identified (814 BRCA1 and 146 BRCA2 carriers). After a mean follow-up of 4.9 years, 41 women (4.3%) developed breast cancer, at a mean age at diagnosis of 57.5 years (range, 39-74). Actuarial cumulative breast cancer risks after ovarian cancer were 4.4%, 8.9%, and 11.5% at 5, 10, and 15 years, respectively. Only three breast cancer-related deaths occurred. Among 741 age-matched BRCA carriers without ovarian cancer, actuarial cumulative risks of breast cancer were 20.9%, 38.6%, and 47.2% at 5, 10, and 15 years, respectively. The hazard ratio for breast cancer, after an ovarian cancer diagnosis, compared with no ovarian cancer, was 0.18 ([95% CI, 0.12 to 0.27]; P < .0001). CONCLUSION: After ovarian cancer, BRCA carriers have a relatively low risk of breast cancer. Risk-reducing mastectomy should not be recommended routinely, but might be considered for long-term survivors. Magnetic resonance imaging surveillance and/or mammography is a realistic alternative.
引用
- Apostol AI, Gronwald J, Cybulski C, et al. Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2. J Clin Oncol. 2026. PMID: 41762747. doi:10.1200/JCO-25-01648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。